Evidence map›Paper›PMID 31399796›Full record

ArticleWorld journal of surgery2020

Prognostic Characteristics of Primary Squamous Cell Carcinoma of the Thyroid: A National Cancer Database Analysis.

Jessica Limberg, Timothy M Ullmann, Dessislava Stefanova, Brendan M Finnerty, Toni Beninato, Thomas J Fahey, Rasa Zarnegar

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jessica LimbergDepartment of Surgery, Weill Cornell Medical College, New York-Presbyterian Hospital, 525 E. 68th St, F-2024, New York, NY, 10065, USA.
Timothy M UllmannDepartment of Surgery, Weill Cornell Medical College, New York-Presbyterian Hospital, 525 E. 68th St, F-2024, New York, NY, 10065, USA.
Dessislava StefanovaDepartment of Surgery, Weill Cornell Medical College, New York-Presbyterian Hospital, 525 E. 68th St, F-2024, New York, NY, 10065, USA.
Brendan M FinnertyDepartment of Surgery, Weill Cornell Medical College, New York-Presbyterian Hospital, 525 E. 68th St, F-2024, New York, NY, 10065, USA.
Toni BeninatoDepartment of Surgery, Weill Cornell Medical College, New York-Presbyterian Hospital, 525 E. 68th St, F-2024, New York, NY, 10065, USA.
Thomas J FaheyDepartment of Surgery, Weill Cornell Medical College, New York-Presbyterian Hospital, 525 E. 68th St, F-2024, New York, NY, 10065, USA.
Rasa ZarnegarDepartment of Surgery, Weill Cornell Medical College, New York-Presbyterian Hospital, 525 E. 68th St, F-2024, New York, NY, 10065, USA. raz2002@med.cornell.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary squamous cell carcinoma of the thyroid (ThySCC) is a rare cancer, primarily described only in case reports. We aimed to characterize the prognosis of ThySCC and compare its oncologic behavior to other thyroid malignancies.

methodsThe National Cancer Database was queried to identify patients with ThySCC, papillary, tall cell variant, poorly differentiated (PDTC), and anaplastic (ATC) subtypes of thyroid cancer treated from 2004 to 2015. Demographics, tumor characteristics, and treatments were compared by tumor type and assessed to identify independent predictors of overall survival (OS).

resultsOf 123,684 patients included, 314 had ThySCC. ThySCC patients had a 5-year OS of 17.7%, more closely resembling ATC (8.3%) than PDTC or PTC. ThySCC and ATC patients had similar demographics, except ThySCC patients who were younger (68.0 vs. 70.2 years, p < 0.01). ThySCC tumors were smaller (mean 53.5 ± 45.7 vs. 69.5 ± 75.2 mm) with less frequent extrathyroidal extension (ETE) (64.0% vs. 73.8%), lymphovascular invasion (8.3% vs. 12.3%), and positive margins (22.0% vs. 28.3%) compared to ATCs (p < 0.05). ETE [HR 3.1 (95% CI 1.5-6.4), p < 0.05] and lymph node metastases [HR 2.2 (95% CI 1.2-4.0) p < 0.05] were independently associated with worse OS for ThySCC patients. Both ThySCC and ATC patients had similar surgical success rates, with R1 resection possible in 37.3% versus 35.0% of patients, respectively (p < 0.05). However, in contrast to ATC patients, adjuvant therapy was not associated with improved OS for ThySCC patients after complete resection.

conclusionsThySCC has a poor prognosis, similar to ATC, but with fewer aggressive features and no apparent survival benefit with adjuvant therapy after complete macroscopic surgical resection.

Indexed as

AdultAgedCarcinoma, Squamous CellDatabases, FactualFemaleHumansLymphatic MetastasisMaleMiddle AgedPrognosisThyroid Neoplasms

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.